Jane Street’s Biodesix BDSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.06M Buy
91,506
+64,475
+239% +$956K ﹤0.01% 5113
2026
Q1
$392K Buy
+27,031
New +$335K ﹤0.01% 8599
2025
Q2
Sell
-3,245
Closed -$40.6K 9622
2025
Q1
$40.6K Sell
3,245
-647
-17% -$12.4K ﹤0.01% 9049
2024
Q4
$119K Buy
+3,892
New +$115K ﹤0.01% 8689
2024
Q2
Sell
-4,644
Closed -$133K 9355
2024
Q1
$133K Buy
4,644
+2,454
+112% +$84K ﹤0.01% 8414
2023
Q4
$80.6K Buy
2,190
+849
+63% +$26.7K ﹤0.01% 8662
2023
Q3
$44.3K Buy
1,341
+682
+103% +$18.9K ﹤0.01% 8178
2023
Q2
$16.2K Buy
+659
New +$19.8K ﹤0.01% 8381

Other funds holding BDSX

Jane Street's BDSX Position: Q2 2026 in Review

Jane Street increased its Biodesix (BDSX) stake by 239% in Q2 2026, buying an estimated $956K and bringing the position to 91,506 shares worth $2.06M. The position accounts for ﹤0.01% of the portfolio, ranked #5113.

Jane Street first reported a position in BDSX in Q2 2023 and has held it in 8 quarters since. 45 funds tracked by Wall St. Rank hold BDSX as of Q2 2026.

  • Jane Street held 91,506 shares of Biodesix worth $2.06M as of Q2 2026.
  • Jane Street bought 64,475 Biodesix shares in Q2 2026, an estimated $956K.
  • Biodesix made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #5113 holding.
  • Jane Street first reported a position in Biodesix in Q2 2023 and has held it in 8 quarters since.
  • 45 funds tracked by Wall St. Rank held Biodesix as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.